Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours

Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours

Item
http://www.wikidata.org/entity/Q34858123
A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factorsFebrile neutropenia in chemotherapy treated small-cell lung cancer patientsChemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy.Prognostic Value of Chemotherapy-Induced Neutropenia at the First Cycle in Invasive Breast Cancer.External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma.Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in patients with non-Hodgkin lymphoma not receiving granulocyte colony-stimulating factor prophylaxis.
P2860

Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours

Item
http://www.wikidata.org/entity/Q34858123
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Risk assessment model for firs ...... in patients with solid tumours
@ast
Risk assessment model for firs ...... in patients with solid tumours
@en
Risk assessment model for firs ...... in patients with solid tumours
@nl
type
label
Risk assessment model for firs ...... in patients with solid tumours
@ast
Risk assessment model for firs ...... in patients with solid tumours
@en
Risk assessment model for firs ...... in patients with solid tumours
@nl
prefLabel
Risk assessment model for firs ...... in patients with solid tumours
@ast
Risk assessment model for firs ...... in patients with solid tumours
@en
Risk assessment model for firs ...... in patients with solid tumours
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Risk assessment model for firs ...... in patients with solid tumours
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2354.2009.01121.X
P407
P433
P478
P577
P5875
P698
P921
P932